Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Transdermal Skin Patches Market Growth 2022-2028

  • LP 4836266
  • 93 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Transdermal Skin Patches will have significant change from previous year. According to our (LP Information) latest study, the global Transdermal Skin Patches market size is USD million in 2022 from USD 41 million in 2021, with a change of % between 2021 and 2022. The global Transdermal Skin Patches market size will reach USD 50 million in 2028, growing at a CAGR of 2.8% over the analysis period.

The United States Transdermal Skin Patches market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Transdermal Skin Patches market, reaching US$ million by the year 2028. As for the Europe Transdermal Skin Patches landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Transdermal Skin Patches players cover Johnson & Johnson, Novartis AG, Mylan N.V., and Teva Pharmaceutical Industries, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Transdermal Skin Patches market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Drug in Adhesive

Matrix

Reservoir

Vapor

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Johnson & Johnson

Novartis AG

Mylan N.V.

Teva Pharmaceutical Industries

Luye Pharma Group

Hisamitsu Pharmaceutical

Mundipharma International

Purdue Pharma

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Transdermal Skin Patches Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Transdermal Skin Patches by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Transdermal Skin Patches by Country/Region, 2017, 2022 & 2028

2.2 Transdermal Skin Patches Segment by Type

2.2.1 Drug in Adhesive

2.2.2 Matrix

2.2.3 Reservoir

2.2.4 Vapor

2.2.5 Others

2.3 Transdermal Skin Patches Sales by Type

2.3.1 Global Transdermal Skin Patches Sales Market Share by Type (2017-2022)

2.3.2 Global Transdermal Skin Patches Revenue and Market Share by Type (2017-2022)

2.3.3 Global Transdermal Skin Patches Sale Price by Type (2017-2022)

2.4 Transdermal Skin Patches Segment by Application

2.4.1 Hospital Pharmacies

2.4.2 Retail Pharmacies

2.4.3 Online Pharmacies

2.5 Transdermal Skin Patches Sales by Application

2.5.1 Global Transdermal Skin Patches Sale Market Share by Application (2017-2022)

2.5.2 Global Transdermal Skin Patches Revenue and Market Share by Application (2017-2022)

2.5.3 Global Transdermal Skin Patches Sale Price by Application (2017-2022)

3 Global Transdermal Skin Patches by Company

3.1 Global Transdermal Skin Patches Breakdown Data by Company

3.1.1 Global Transdermal Skin Patches Annual Sales by Company (2020-2022)

3.1.2 Global Transdermal Skin Patches Sales Market Share by Company (2020-2022)

3.2 Global Transdermal Skin Patches Annual Revenue by Company (2020-2022)

3.2.1 Global Transdermal Skin Patches Revenue by Company (2020-2022)

3.2.2 Global Transdermal Skin Patches Revenue Market Share by Company (2020-2022)

3.3 Global Transdermal Skin Patches Sale Price by Company

3.4 Key Manufacturers Transdermal Skin Patches Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Transdermal Skin Patches Product Location Distribution

3.4.2 Players Transdermal Skin Patches Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Transdermal Skin Patches by Geographic Region

4.1 World Historic Transdermal Skin Patches Market Size by Geographic Region (2017-2022)

4.1.1 Global Transdermal Skin Patches Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Transdermal Skin Patches Annual Revenue by Geographic Region

4.2 World Historic Transdermal Skin Patches Market Size by Country/Region (2017-2022)

4.2.1 Global Transdermal Skin Patches Annual Sales by Country/Region (2017-2022)

4.2.2 Global Transdermal Skin Patches Annual Revenue by Country/Region

4.3 Americas Transdermal Skin Patches Sales Growth

4.4 APAC Transdermal Skin Patches Sales Growth

4.5 Europe Transdermal Skin Patches Sales Growth

4.6 Middle East & Africa Transdermal Skin Patches Sales Growth

5 Americas

5.1 Americas Transdermal Skin Patches Sales by Country

5.1.1 Americas Transdermal Skin Patches Sales by Country (2017-2022)

5.1.2 Americas Transdermal Skin Patches Revenue by Country (2017-2022)

5.2 Americas Transdermal Skin Patches Sales by Type

5.3 Americas Transdermal Skin Patches Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Transdermal Skin Patches Sales by Region

6.1.1 APAC Transdermal Skin Patches Sales by Region (2017-2022)

6.1.2 APAC Transdermal Skin Patches Revenue by Region (2017-2022)

6.2 APAC Transdermal Skin Patches Sales by Type

6.3 APAC Transdermal Skin Patches Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Transdermal Skin Patches by Country

7.1.1 Europe Transdermal Skin Patches Sales by Country (2017-2022)

7.1.2 Europe Transdermal Skin Patches Revenue by Country (2017-2022)

7.2 Europe Transdermal Skin Patches Sales by Type

7.3 Europe Transdermal Skin Patches Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Transdermal Skin Patches by Country

8.1.1 Middle East & Africa Transdermal Skin Patches Sales by Country (2017-2022)

8.1.2 Middle East & Africa Transdermal Skin Patches Revenue by Country (2017-2022)

8.2 Middle East & Africa Transdermal Skin Patches Sales by Type

8.3 Middle East & Africa Transdermal Skin Patches Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Transdermal Skin Patches

10.3 Manufacturing Process Analysis of Transdermal Skin Patches

10.4 Industry Chain Structure of Transdermal Skin Patches

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Transdermal Skin Patches Distributors

11.3 Transdermal Skin Patches Customer

12 World Forecast Review for Transdermal Skin Patches by Geographic Region

12.1 Global Transdermal Skin Patches Market Size Forecast by Region

12.1.1 Global Transdermal Skin Patches Forecast by Region (2023-2028)

12.1.2 Global Transdermal Skin Patches Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Transdermal Skin Patches Forecast by Type

12.7 Global Transdermal Skin Patches Forecast by Application

13 Key Players Analysis

13.1 Johnson & Johnson

13.1.1 Johnson & Johnson Company Information

13.1.2 Johnson & Johnson Transdermal Skin Patches Product Offered

13.1.3 Johnson & Johnson Transdermal Skin Patches Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Johnson & Johnson Main Business Overview

13.1.5 Johnson & Johnson Latest Developments

13.2 Novartis AG

13.2.1 Novartis AG Company Information

13.2.2 Novartis AG Transdermal Skin Patches Product Offered

13.2.3 Novartis AG Transdermal Skin Patches Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Novartis AG Main Business Overview

13.2.5 Novartis AG Latest Developments

13.3 Mylan N.V.

13.3.1 Mylan N.V. Company Information

13.3.2 Mylan N.V. Transdermal Skin Patches Product Offered

13.3.3 Mylan N.V. Transdermal Skin Patches Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Mylan N.V. Main Business Overview

13.3.5 Mylan N.V. Latest Developments

13.4 Teva Pharmaceutical Industries

13.4.1 Teva Pharmaceutical Industries Company Information

13.4.2 Teva Pharmaceutical Industries Transdermal Skin Patches Product Offered

13.4.3 Teva Pharmaceutical Industries Transdermal Skin Patches Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Teva Pharmaceutical Industries Main Business Overview

13.4.5 Teva Pharmaceutical Industries Latest Developments

13.5 Luye Pharma Group

13.5.1 Luye Pharma Group Company Information

13.5.2 Luye Pharma Group Transdermal Skin Patches Product Offered

13.5.3 Luye Pharma Group Transdermal Skin Patches Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Luye Pharma Group Main Business Overview

13.5.5 Luye Pharma Group Latest Developments

13.6 Hisamitsu Pharmaceutical

13.6.1 Hisamitsu Pharmaceutical Company Information

13.6.2 Hisamitsu Pharmaceutical Transdermal Skin Patches Product Offered

13.6.3 Hisamitsu Pharmaceutical Transdermal Skin Patches Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Hisamitsu Pharmaceutical Main Business Overview

13.6.5 Hisamitsu Pharmaceutical Latest Developments

13.7 Mundipharma International

13.7.1 Mundipharma International Company Information

13.7.2 Mundipharma International Transdermal Skin Patches Product Offered

13.7.3 Mundipharma International Transdermal Skin Patches Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Mundipharma International Main Business Overview

13.7.5 Mundipharma International Latest Developments

13.8 Purdue Pharma

13.8.1 Purdue Pharma Company Information

13.8.2 Purdue Pharma Transdermal Skin Patches Product Offered

13.8.3 Purdue Pharma Transdermal Skin Patches Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Purdue Pharma Main Business Overview

13.8.5 Purdue Pharma Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Transdermal Skin Patches Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Transdermal Skin Patches Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Drug in Adhesive

Table 4. Major Players of Matrix

Table 5. Major Players of Reservoir

Table 6. Major Players of Vapor

Table 7. Major Players of Others

Table 8. Global Transdermal Skin Patches Sales by Type (2017-2022) & (M Pcs)

Table 9. Global Transdermal Skin Patches Sales Market Share by Type (2017-2022)

Table 10. Global Transdermal Skin Patches Revenue by Type (2017-2022) & ($ million)

Table 11. Global Transdermal Skin Patches Revenue Market Share by Type (2017-2022)

Table 12. Global Transdermal Skin Patches Sale Price by Type (2017-2022) & (USD/Pcs)

Table 13. Global Transdermal Skin Patches Sales by Application (2017-2022) & (M Pcs)

Table 14. Global Transdermal Skin Patches Sales Market Share by Application (2017-2022)

Table 15. Global Transdermal Skin Patches Revenue by Application (2017-2022)

Table 16. Global Transdermal Skin Patches Revenue Market Share by Application (2017-2022)

Table 17. Global Transdermal Skin Patches Sale Price by Application (2017-2022) & (USD/Pcs)

Table 18. Global Transdermal Skin Patches Sales by Company (2020-2022) & (M Pcs)

Table 19. Global Transdermal Skin Patches Sales Market Share by Company (2020-2022)

Table 20. Global Transdermal Skin Patches Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Transdermal Skin Patches Revenue Market Share by Company (2020-2022)

Table 22. Global Transdermal Skin Patches Sale Price by Company (2020-2022) & (USD/Pcs)

Table 23. Key Manufacturers Transdermal Skin Patches Producing Area Distribution and Sales Area

Table 24. Players Transdermal Skin Patches Products Offered

Table 25. Transdermal Skin Patches Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Transdermal Skin Patches Sales by Geographic Region (2017-2022) & (M Pcs)

Table 29. Global Transdermal Skin Patches Sales Market Share Geographic Region (2017-2022)

Table 30. Global Transdermal Skin Patches Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Transdermal Skin Patches Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Transdermal Skin Patches Sales by Country/Region (2017-2022) & (M Pcs)

Table 33. Global Transdermal Skin Patches Sales Market Share by Country/Region (2017-2022)

Table 34. Global Transdermal Skin Patches Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Transdermal Skin Patches Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Transdermal Skin Patches Sales by Country (2017-2022) & (M Pcs)

Table 37. Americas Transdermal Skin Patches Sales Market Share by Country (2017-2022)

Table 38. Americas Transdermal Skin Patches Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Transdermal Skin Patches Revenue Market Share by Country (2017-2022)

Table 40. Americas Transdermal Skin Patches Sales by Type (2017-2022) & (M Pcs)

Table 41. Americas Transdermal Skin Patches Sales Market Share by Type (2017-2022)

Table 42. Americas Transdermal Skin Patches Sales by Application (2017-2022) & (M Pcs)

Table 43. Americas Transdermal Skin Patches Sales Market Share by Application (2017-2022)

Table 44. APAC Transdermal Skin Patches Sales by Region (2017-2022) & (M Pcs)

Table 45. APAC Transdermal Skin Patches Sales Market Share by Region (2017-2022)

Table 46. APAC Transdermal Skin Patches Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Transdermal Skin Patches Revenue Market Share by Region (2017-2022)

Table 48. APAC Transdermal Skin Patches Sales by Type (2017-2022) & (M Pcs)

Table 49. APAC Transdermal Skin Patches Sales Market Share by Type (2017-2022)

Table 50. APAC Transdermal Skin Patches Sales by Application (2017-2022) & (M Pcs)

Table 51. APAC Transdermal Skin Patches Sales Market Share by Application (2017-2022)

Table 52. Europe Transdermal Skin Patches Sales by Country (2017-2022) & (M Pcs)

Table 53. Europe Transdermal Skin Patches Sales Market Share by Country (2017-2022)

Table 54. Europe Transdermal Skin Patches Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Transdermal Skin Patches Revenue Market Share by Country (2017-2022)

Table 56. Europe Transdermal Skin Patches Sales by Type (2017-2022) & (M Pcs)

Table 57. Europe Transdermal Skin Patches Sales Market Share by Type (2017-2022)

Table 58. Europe Transdermal Skin Patches Sales by Application (2017-2022) & (M Pcs)

Table 59. Europe Transdermal Skin Patches Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Transdermal Skin Patches Sales by Country (2017-2022) & (M Pcs)

Table 61. Middle East & Africa Transdermal Skin Patches Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Transdermal Skin Patches Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Transdermal Skin Patches Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Transdermal Skin Patches Sales by Type (2017-2022) & (M Pcs)

Table 65. Middle East & Africa Transdermal Skin Patches Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Transdermal Skin Patches Sales by Application (2017-2022) & (M Pcs)

Table 67. Middle East & Africa Transdermal Skin Patches Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Transdermal Skin Patches

Table 69. Key Market Challenges & Risks of Transdermal Skin Patches

Table 70. Key Industry Trends of Transdermal Skin Patches

Table 71. Transdermal Skin Patches Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Transdermal Skin Patches Distributors List

Table 74. Transdermal Skin Patches Customer List

Table 75. Global Transdermal Skin Patches Sales Forecast by Region (2023-2028) & (M Pcs)

Table 76. Global Transdermal Skin Patches Sales Market Forecast by Region

Table 77. Global Transdermal Skin Patches Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Transdermal Skin Patches Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Transdermal Skin Patches Sales Forecast by Country (2023-2028) & (M Pcs)

Table 80. Americas Transdermal Skin Patches Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Transdermal Skin Patches Sales Forecast by Region (2023-2028) & (M Pcs)

Table 82. APAC Transdermal Skin Patches Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Transdermal Skin Patches Sales Forecast by Country (2023-2028) & (M Pcs)

Table 84. Europe Transdermal Skin Patches Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Transdermal Skin Patches Sales Forecast by Country (2023-2028) & (M Pcs)

Table 86. Middle East & Africa Transdermal Skin Patches Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Transdermal Skin Patches Sales Forecast by Type (2023-2028) & (M Pcs)

Table 88. Global Transdermal Skin Patches Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Transdermal Skin Patches Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Transdermal Skin Patches Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Transdermal Skin Patches Sales Forecast by Application (2023-2028) & (M Pcs)

Table 92. Global Transdermal Skin Patches Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Transdermal Skin Patches Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Transdermal Skin Patches Revenue Market Share Forecast by Application (2023-2028)

Table 95. Johnson & Johnson Basic Information, Transdermal Skin Patches Manufacturing Base, Sales Area and Its Competitors

Table 96. Johnson & Johnson Transdermal Skin Patches Product Offered

Table 97. Johnson & Johnson Transdermal Skin Patches Sales (M Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 98. Johnson & Johnson Main Business

Table 99. Johnson & Johnson Latest Developments

Table 100. Novartis AG Basic Information, Transdermal Skin Patches Manufacturing Base, Sales Area and Its Competitors

Table 101. Novartis AG Transdermal Skin Patches Product Offered

Table 102. Novartis AG Transdermal Skin Patches Sales (M Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 103. Novartis AG Main Business

Table 104. Novartis AG Latest Developments

Table 105. Mylan N.V. Basic Information, Transdermal Skin Patches Manufacturing Base, Sales Area and Its Competitors

Table 106. Mylan N.V. Transdermal Skin Patches Product Offered

Table 107. Mylan N.V. Transdermal Skin Patches Sales (M Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 108. Mylan N.V. Main Business

Table 109. Mylan N.V. Latest Developments

Table 110. Teva Pharmaceutical Industries Basic Information, Transdermal Skin Patches Manufacturing Base, Sales Area and Its Competitors

Table 111. Teva Pharmaceutical Industries Transdermal Skin Patches Product Offered

Table 112. Teva Pharmaceutical Industries Transdermal Skin Patches Sales (M Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 113. Teva Pharmaceutical Industries Main Business

Table 114. Teva Pharmaceutical Industries Latest Developments

Table 115. Luye Pharma Group Basic Information, Transdermal Skin Patches Manufacturing Base, Sales Area and Its Competitors

Table 116. Luye Pharma Group Transdermal Skin Patches Product Offered

Table 117. Luye Pharma Group Transdermal Skin Patches Sales (M Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 118. Luye Pharma Group Main Business

Table 119. Luye Pharma Group Latest Developments

Table 120. Hisamitsu Pharmaceutical Basic Information, Transdermal Skin Patches Manufacturing Base, Sales Area and Its Competitors

Table 121. Hisamitsu Pharmaceutical Transdermal Skin Patches Product Offered

Table 122. Hisamitsu Pharmaceutical Transdermal Skin Patches Sales (M Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 123. Hisamitsu Pharmaceutical Main Business

Table 124. Hisamitsu Pharmaceutical Latest Developments

Table 125. Mundipharma International Basic Information, Transdermal Skin Patches Manufacturing Base, Sales Area and Its Competitors

Table 126. Mundipharma International Transdermal Skin Patches Product Offered

Table 127. Mundipharma International Transdermal Skin Patches Sales (M Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 128. Mundipharma International Main Business

Table 129. Mundipharma International Latest Developments

Table 130. Purdue Pharma Basic Information, Transdermal Skin Patches Manufacturing Base, Sales Area and Its Competitors

Table 131. Purdue Pharma Transdermal Skin Patches Product Offered

Table 132. Purdue Pharma Transdermal Skin Patches Sales (M Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 133. Purdue Pharma Main Business

Table 134. Purdue Pharma Latest Developments

List of Figures

Figure 1. Picture of Transdermal Skin Patches

Figure 2. Transdermal Skin Patches Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Transdermal Skin Patches Sales Growth Rate 2017-2028 (M Pcs)

Figure 7. Global Transdermal Skin Patches Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Transdermal Skin Patches Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Drug in Adhesive

Figure 10. Product Picture of Matrix

Figure 11. Product Picture of Reservoir

Figure 12. Product Picture of Vapor

Figure 13. Product Picture of Others

Figure 14. Global Transdermal Skin Patches Sales Market Share by Type in 2021

Figure 15. Global Transdermal Skin Patches Revenue Market Share by Type (2017-2022)

Figure 16. Transdermal Skin Patches Consumed in Hospital Pharmacies

Figure 17. Global Transdermal Skin Patches Market: Hospital Pharmacies (2017-2022) & (M Pcs)

Figure 18. Transdermal Skin Patches Consumed in Retail Pharmacies

Figure 19. Global Transdermal Skin Patches Market: Retail Pharmacies (2017-2022) & (M Pcs)

Figure 20. Transdermal Skin Patches Consumed in Online Pharmacies

Figure 21. Global Transdermal Skin Patches Market: Online Pharmacies (2017-2022) & (M Pcs)

Figure 22. Global Transdermal Skin Patches Sales Market Share by Application (2017-2022)

Figure 23. Global Transdermal Skin Patches Revenue Market Share by Application in 2021

Figure 24. Transdermal Skin Patches Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Transdermal Skin Patches Revenue Market Share by Company in 2021

Figure 26. Global Transdermal Skin Patches Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Transdermal Skin Patches Revenue Market Share by Geographic Region in 2021

Figure 28. Global Transdermal Skin Patches Sales Market Share by Region (2017-2022)

Figure 29. Global Transdermal Skin Patches Revenue Market Share by Country/Region in 2021

Figure 30. Americas Transdermal Skin Patches Sales 2017-2022 (M Pcs)

Figure 31. Americas Transdermal Skin Patches Revenue 2017-2022 ($ Millions)

Figure 32. APAC Transdermal Skin Patches Sales 2017-2022 (M Pcs)

Figure 33. APAC Transdermal Skin Patches Revenue 2017-2022 ($ Millions)

Figure 34. Europe Transdermal Skin Patches Sales 2017-2022 (M Pcs)

Figure 35. Europe Transdermal Skin Patches Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Transdermal Skin Patches Sales 2017-2022 (M Pcs)

Figure 37. Middle East & Africa Transdermal Skin Patches Revenue 2017-2022 ($ Millions)

Figure 38. Americas Transdermal Skin Patches Sales Market Share by Country in 2021

Figure 39. Americas Transdermal Skin Patches Revenue Market Share by Country in 2021

Figure 40. United States Transdermal Skin Patches Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Transdermal Skin Patches Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Transdermal Skin Patches Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Transdermal Skin Patches Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Transdermal Skin Patches Sales Market Share by Region in 2021

Figure 45. APAC Transdermal Skin Patches Revenue Market Share by Regions in 2021

Figure 46. China Transdermal Skin Patches Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Transdermal Skin Patches Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Transdermal Skin Patches Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Transdermal Skin Patches Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Transdermal Skin Patches Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Transdermal Skin Patches Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Transdermal Skin Patches Sales Market Share by Country in 2021

Figure 53. Europe Transdermal Skin Patches Revenue Market Share by Country in 2021

Figure 54. Germany Transdermal Skin Patches Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Transdermal Skin Patches Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Transdermal Skin Patches Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Transdermal Skin Patches Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Transdermal Skin Patches Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Transdermal Skin Patches Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Transdermal Skin Patches Revenue Market Share by Country in 2021

Figure 61. Egypt Transdermal Skin Patches Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Transdermal Skin Patches Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Transdermal Skin Patches Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Transdermal Skin Patches Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Transdermal Skin Patches Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Transdermal Skin Patches in 2021

Figure 67. Manufacturing Process Analysis of Transdermal Skin Patches

Figure 68. Industry Chain Structure of Transdermal Skin Patches

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390